On Oct. 21, Analysis Capital analyst Andre Uddin reaffirmed his “Purchase” score and C$3.75 goal value on Covalon Applied sciences (Covalon Applied sciences Inventory Quote, Chart, Information, Analysts, Financials TSXV:COV) after the Mississauga-based medical gadget firm introduced a one-time money dividend of C$0.15 per share, representing a 7.2% yield at its present value of C$2.08.
The dividend, totalling roughly C$4.1-million, can be paid Nov. 18, to shareholders of file as of Nov. 4, throughout Covalon’s fiscal first quarter of 2026. As of June 30, the corporate reported C$18.1-million in money and no long-term debt, giving it what Uddin referred to as a “pristine steadiness sheet.”
“Given the dividend can be paid in November, we don’t count on any speedy affect on Covalon’s money place and estimate the present steadiness at roughly C$16-million,” Uddin stated. “This fee is a one-time particular distribution and doesn’t essentially indicate a recurring dividend coverage shifting ahead.”
He stated the choice probably alerts a diminished chance of near-term acquisitions, although he continues to view Covalon as a GARP inventory.
“We’re sustaining our ‘Purchase’ score and sustaining our goal value of C$3.75 primarily based on the valuations of worldwide wound care and superior dressing corporations,” he stated.
Analysis Capital’s valuation relies on a blended EV/gross sales a number of of two.4× utilized to estimated 2025 gross sales of C$36-million, in line with peer multiples of worldwide wound-care and dressing corporations resembling Convatec, Organogenesis, Mimedx Group, and Integra LifeSciences.
The agency’s monetary mannequin tasks Covalon’s EPS of C$0.06 for 2025, following C$0.11 in 2024, on income rising from C$31-million final 12 months to C$36-million in 2025.
Uddin reiterated that Covalon “stays a well-positioned, underappreciated title within the superior wound-care area,” benefiting from a strong money place and the potential for longer-term a number of enlargement because it grows its gross sales base.
Covalon designs and manufactures wound care, vascular entry, and perioperative merchandise, and markets its portfolio within the U.S., Canada, the Center East, and Latin America.
-30-
Elevate your perspective with NextTech Information, the place innovation meets perception.
Uncover the most recent breakthroughs, get unique updates, and join with a world community of future-focused thinkers.
Unlock tomorrow’s traits at present: learn extra, subscribe to our e-newsletter, and grow to be a part of the NextTech group at NextTech-news.com
